Literature DB >> 35841421

Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma.

Xin-Wen Zhang1, Alexander Wald2, Martin Salzmann2, Niels Halama3, Jessica C Hassel2.   

Abstract

BACKGROUND: Paraneoplastic leukemoid reaction (PLR) is a rare phenomenon in metastasized melanoma associated with poor prognosis and rapid disease progression. Currently, no specific therapeutic options exist other than treating the underlying malignancy.
METHODS: Five cases of paraneoplastic neutrophilia in patients with advanced-stage IV melanoma were enrolled in our study. Cytokine concentrations in patients' serum samples were analyzed before and during PLR using a multiplex cytokine array. Further, immunohistochemical staining of tumor tissue biopsied during PLR was performed. RESULTS AND
CONCLUSIONS: We observed a strong correlation between worsening of tumor burden and aggravation of neutrophilia. Cytokine measurements revealed an increase of proinflammatory cytokines (IL6, IFNγ), proangiogenic cytokines (VEGF) and immune stem cell growth factors (G-CSF) during PLR. Immunohistochemistry confirmed neutrophil infiltration of tumor tissue. The presented cytokine alterations provide a basis for further functional analysis, which is necessary for the development of targeted therapeutic approaches against PLR.
© 2022. The Author(s).

Entities:  

Keywords:  Cytokines; Inflammation; Melanoma; Neutrophils; Paraneoplastic leukemoid reaction

Year:  2022        PMID: 35841421     DOI: 10.1007/s00262-022-03249-7

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.630


  12 in total

Review 1.  Paraneoplastic granulocytosis in metastatic melanoma.

Authors:  Jeremy L Davis; R Taylor Ripley; Timothy L Frankel; Irina Maric; Jay N Lozier; Steven A Rosenberg
Journal:  Melanoma Res       Date:  2010-08       Impact factor: 3.599

2.  Paraneoplastic Leukemoid Reaction as a Marker of Tumor Progression in Non-Small Cell Lung Cancer.

Authors:  Caroline E McCoach; Jessica G Rogers; Denis M Dwyre; Brian A Jonas
Journal:  Cancer Treat Commun       Date:  2015

Review 3.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

4.  Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell line.

Authors:  Bodo Schniewind; Matthias Christgen; Axel Hauschild; Roland Kurdow; Holger Kalthoff; Hans Jürgen Klomp
Journal:  Cancer Biol Ther       Date:  2005-01-09       Impact factor: 4.742

5.  Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma.

Authors:  Azaz Ahmed; Sophia Köhler; Rosa Klotz; Nathalia Giese; Felix Lasitschka; Thilo Hackert; Christoph Springfeld; Inka Zörnig; Dirk Jäger; Niels Halama
Journal:  Oncoimmunology       Date:  2021-08-10       Impact factor: 8.110

6.  Herlyn-Werner-Wunderlich and Prader-Willi syndromes: more than a coincidence?

Authors:  Beatriz Fraga; Catarina Gomes; Raquel Gouveia; Graça Oliveira
Journal:  BMJ Case Rep       Date:  2015-10-21

7.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

8.  Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition.

Authors:  Andressa S Laino; David Woods; Melinda Vassallo; Xiaozhong Qian; Hao Tang; Megan Wind-Rotolo; Jeffrey Weber
Journal:  J Immunother Cancer       Date:  2020-06-23       Impact factor: 13.751

9.  Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma.

Authors:  Maria Åström; Walid Tajeddinn; Mats G Karlsson; Olle Linder; Jan Palmblad; Per Lindblad
Journal:  Biomark Insights       Date:  2018-08-17

Review 10.  Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours.

Authors:  Ibrahim A Abukhiran; Judy Jasser; Sergei Syrbu
Journal:  J Clin Pathol       Date:  2020-01-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.